| Authors: |
Luu RJ; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Hoefler BC; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Gard AL; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Ritenour CR; Pfizer Inc., Groton, CT, United States., Rogers MT; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Kim ES; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Coppeta JR; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Cain BP; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Isenberg BC; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Azizgolshani H; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Fajardo-Ramirez OR; Laboratory for Systems Mechanobiology, Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., García-Cardeña G; Laboratory for Systems Mechanobiology, Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Lech MP; Pfizer Inc., Cambridge, MA, United States., Tomlinson L; Pfizer Inc., Cambridge, MA, United States., Charest JL; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States., Williams C; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States. |
